SCHOENBERG MARK (Chief Medical Officer) sold 0.6% of their position (859.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $11.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/12/2024ACC: 0001437749-24-029040
Officer· Chief Medical Officer
Since Jan 2019
-859.00
Net shares
Net seller
$11.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.67K acquired · 2.52K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.67K
Price / share
—
Trade value
—
% of position
1.2%
9/9/2024
144.28K→145.95K
Ordinary Shares
Direct
Shares
−859.00
Price / share
$13.08
Trade value
$11.24K
% of position
0.6%
9/9/2024
145.95K→145.09K
Total
Net shares
+807.00
Net value
-$11.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/9/2024 | M · Option Exercise | +1.67K | — | — | 1.2% | 144.28K | 145.95K |
| Ordinary Shares Direct | 9/9/2024 | S · Sale | −859.00 | $13.08 | $11.24K | 0.6% | 145.95K | 145.09K |
| Total | +807.00 | -$11.24K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.67K shares
Shares
−1.67K
Strike price
Held after
3.33K
Exercisable
—
9/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.67K shares | 9/9/2024 | M · Option Exercise | −1.67K | — | 3.33K |